Brazil court strips Gilead hepatitis drug patent, politician says
A Brazilian court has stripped the patent protection of a Gilead Sciences Inc big-selling hepatitis C treatment in Brazil, paving the way for cheaper generics, a presidential candidate who pushed for the move said on Monday.
from Reuters: Health News https://reut.rs/2xC480F
http://bit.ly/2zwRqiM
September 24, 2018
|
Labels:
health,
Reuters: Health News
|
This entry was posted on September 24, 2018
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.